Suppr超能文献

采用多元矩阵代谢组学结合血清药物化学方法研究芪附汤治疗心力衰竭的潜在作用靶点和有效成分。

Multiple-matrices metabolomics combined with serum pharmacochemistry for discovering the potential targets and active constituents of Qifu decoction against heart failure.

机构信息

School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an 712046, China; School of Pharmacy, Air Force Medical University, Xi'an 710032, China.

School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

出版信息

J Pharm Biomed Anal. 2024 Jul 15;244:116114. doi: 10.1016/j.jpba.2024.116114. Epub 2024 Mar 16.

Abstract

Qifu decoction (QFD) is an ancient traditional Chinese medicine (TCM) prescription for the treatment of heart failure. However, the mechanisms and active constituents of QFD are poorly understood. In this study, multi-matrices metabolomics (serum, urine, and myocardial mitochondria) based on ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOFMS), were employed for exploring the mechanisms of QFD against heart failure in rat model. Twenty-one, seventeen, and fifteen endogenous metabolite biomarkers associated with heart failure were identified from serum, urine, and myocardial mitochondria datasets, respectively. Fourteen, twelve, and ten of the identified serum, urine, and mitochondria biomarkers were significantly reversed by QFD, respectively. QFD-targeted pathways were involved in TCA cycle, branched chain amino acids metabolism, fatty acid β-oxidation, sphingolipid metabolism, glycerophospholipid metabolism, arachidonic acid metabolism, tryptophan metabolism, purine metabolism. In addition, QFD-derived constituents in serum were fully analyzed by UHPLC-Q-TOFMS and SUS-plot, and 24 QFD-derived components were identified in serum. Then, the correlation analysis between the QFD-reversed serum biomarkers and QFD-derived constituents in serum was employed to dissect the active constituents of QFD. It was found that eight prototypical components and three metabolites were highly correlated with efficacy and could serve as the active constituents of QFD against heart failure. Finally, neoline and calycosin, which highly correlated with branched-chain amino acid metabolism and fatty acid β-oxidation, were selected to validate in NaSO-induced cell model. It was found that neoline and calycosin provided a significant protective effect against NaSO-induced cell death in a low dose-dependent manner and increased the expressions of the pathway-related protein CPT1B and BCAT2 in the cell model. In conclusions, these findings provided light on the mechanisms and active constituents of QFD against heart failure. Neoline and calycosin could be selected as potential quality-markers of QFD against heart failure.

摘要

芪附汤(QFD)是一种治疗心力衰竭的古老中药(TCM)方剂。然而,其机制和有效成分尚不清楚。在这项研究中,采用基于超高效液相色谱-四极杆飞行时间质谱联用(UHPLC-Q-TOFMS)的多基质代谢组学(血清、尿液和心肌线粒体),探索 QFD 对心力衰竭大鼠模型的作用机制。从血清、尿液和心肌线粒体数据集中分别鉴定出与心力衰竭相关的 21、17 和 15 种内源性代谢生物标志物。QFD 分别显著逆转了 14、12 和 10 种鉴定出的血清、尿液和线粒体生物标志物。QFD 靶向途径涉及三羧酸循环、支链氨基酸代谢、脂肪酸β-氧化、鞘脂代谢、甘油磷脂代谢、花生四烯酸代谢、色氨酸代谢、嘌呤代谢。此外,通过 UHPLC-Q-TOFMS 和 SUS-plot 对 QFD 衍生的血清成分进行了全面分析,共鉴定出 24 种 QFD 衍生的血清成分。然后,对 QFD 逆转的血清生物标志物与血清中 QFD 衍生成分之间的相关性进行分析,以剖析 QFD 的有效成分。结果发现,八种原型成分和三种代谢物与疗效高度相关,可作为 QFD 治疗心力衰竭的有效成分。最后,选择与支链氨基酸代谢和脂肪酸β-氧化高度相关的新诺林和毛蕊异黄酮在 NaSO 诱导的细胞模型中进行验证。结果发现,新诺林和毛蕊异黄酮以剂量依赖的方式对 NaSO 诱导的细胞死亡提供了显著的保护作用,并增加了细胞模型中途径相关蛋白 CPT1B 和 BCAT2 的表达。总之,这些发现为 QFD 治疗心力衰竭的机制和有效成分提供了线索。新诺林和毛蕊异黄酮可作为 QFD 治疗心力衰竭的潜在质量标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验